Persistent methicillin-resistant Staphylococcus aureus bacteremia: do we need a new therapeutic strategy?

Affiliations

Comment

Cheol-In Kang. Korean J Intern Med. 2013 Nov.

. 2013 Nov;28(6):657-9.

doi: 10.3904/kjim.2013.28.6.657. Epub 2013 Oct 29.

¹ Division of Infectious Diseases, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

No abstract available

Conflict of interest statement

No potential conflict of interest relevant to this article is reported.

Predictors and clinical outcomes of persistent methicillin-resistant Staphylococcus aureus bacteremia: a prospective observational study.
Ok HS, Lee HS, Park MJ, Kim KH, Kim BK, Wi YM, Kim JM. Ok HS, et al. Korean J Intern Med. 2013 Nov;28(6):678-86. doi: 10.3904/kjim.2013.28.6.678. Epub 2013 Oct 29. Korean J Intern Med. 2013. PMID: 24307843 Free PMC article.

1. Tremblay S, Lau TT, Ensom MH. Addition of rifampin to vancomycin for methicillin-resistant Staphylococcus aureus infections: what is the evidence? Ann Pharmacother. 2013;47:1045–1054. - PubMed
1. Jang HC, Kim SH, Kim KH, et al. Salvage treatment for persistent methicillin-resistant Staphylococcus aureus bacteremia: efficacy of linezolid with or without carbapenem. Clin Infect Dis. 2009;49:395–401. - PubMed
1. Yoon YK, Kim JY, Park DW, Sohn JW, Kim MJ. Predictors of persistent methicillin-resistant Staphylococcus aureus bacteraemia in patients treated with vancomycin. J Antimicrob Chemother. 2010;65:1015–1018. - PubMed
1. Chong YP, Park SJ, Kim HS, et al. Persistent Staphylococcus aureus bacteremia: a prospective analysis of risk factors, outcomes, and microbiologic and genotypic characteristics of isolates. Medicine (Baltimore) 2013;92:98–108. - PMC - PubMed
1. Park SY, Chong YP, Park HJ, et al. agr Dysfunction and persistent methicillin-resistant Staphylococcus aureus bacteremia in patients with removed eradicable foci. Infection. 2013;41:111–119. - PubMed